222 related articles for article (PubMed ID: 37892663)
1. Current Evidence for the Use of HIPEC and Cytoreductive Surgery in Gastric Cancer Metastatic to the Peritoneum.
Jain AJ; Badgwell BD
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892663
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
3. Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials.
Granieri S; Bonomi A; Frassini S; Chierici AP; Bruno F; Paleino S; Kusamura S; Germini A; Facciorusso A; Deraco M; Cotsoglou C
Eur J Surg Oncol; 2021 Nov; 47(11):2757-2767. PubMed ID: 34001385
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: a systematic review.
Eveno C; Pocard M
Pleura Peritoneum; 2016 Dec; 1(4):169-182. PubMed ID: 30911621
[TBL] [Abstract][Full Text] [Related]
5. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.
Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
Curr Oncol; 2020 Jun; 27(3):146-154. PubMed ID: 32669924
[TBL] [Abstract][Full Text] [Related]
6. Initial Experience of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Baltic Country Center.
Račkauskas R; Baušys A; Jurgaitis J; Paškonis M; Strupas K
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233421
[No Abstract] [Full Text] [Related]
7. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
van der Kaaij RT; Braam HJ; Boot H; Los M; Cats A; Grootscholten C; Schellens JH; Aalbers AG; Huitema AD; Knibbe CA; Boerma D; Wiezer MJ; van Ramshorst B; van Sandick JW
JMIR Res Protoc; 2017 Jul; 6(7):e136. PubMed ID: 28705789
[TBL] [Abstract][Full Text] [Related]
8. The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.
Seshadri RA; Glehen O
Indian J Surg Oncol; 2016 Jun; 7(2):198-207. PubMed ID: 27065710
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis.
Ellison LM; Man Y; Stojadinovic A; Xin H; Avital I
Chin J Cancer Res; 2017 Feb; 29(1):86-92. PubMed ID: 28373757
[TBL] [Abstract][Full Text] [Related]
10. The Landmark Series: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for Treatment of Gastric Cancer Metastatic to Peritoneum.
Dineen SP; Pimiento JM
Ann Surg Oncol; 2021 Aug; 28(8):4130-4137. PubMed ID: 33856601
[TBL] [Abstract][Full Text] [Related]
11. Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials.
Jian C; Mou H; Zhang Y; Fan Q; Ou Y
Front Pharmacol; 2023; 14():1094834. PubMed ID: 36969856
[No Abstract] [Full Text] [Related]
12. Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies-A Comprehensive Review.
Eftimie MA; Potlog G; Alexandrescu ST
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837456
[TBL] [Abstract][Full Text] [Related]
13. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
Eur J Cancer; 2020 Mar; 127():76-95. PubMed ID: 31986452
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
[TBL] [Abstract][Full Text] [Related]
15. HIPEC with CRS versus cytoreductive surgery (CRS) for the gastric cancer metastasis to peritoneum.
Chen Z; Ali M; Kai Z; Wang Y; Wang C
Clin Transl Oncol; 2023 Apr; 25(4):1011-1016. PubMed ID: 36401054
[TBL] [Abstract][Full Text] [Related]
16. Update of randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: a systematic review.
Noiret B; Piessen G; Eveno C
Pleura Peritoneum; 2022 Jun; 7(2):51-61. PubMed ID: 35812007
[TBL] [Abstract][Full Text] [Related]
17. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.
Canbay E; Canbay Torun B; Cosarcan K; Altunal C; Gurbuz B; Bilgic C; Sezgin C; Kaban KK; Yilmaz S; Yazici Z
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S47-S56. PubMed ID: 33968425
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in small bowel adenocarcinoma with peritoneal metastasis: a systematic review.
Chen V; Jones M; Cohen L; Yang W; Bedi J; Mohan HM; Apte SS; Larach JT; Flood M; Heriot A; Kong J; Warrier S
Pleura Peritoneum; 2022 Dec; 7(4):159-167. PubMed ID: 36560970
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
[TBL] [Abstract][Full Text] [Related]
20. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
